Onco-Hematology

BARC holds a specific know-how in onco-hematology studies, both regarding the management of cutting-edge techniques and the multi-layered expertise necessary for conducting tests with an added value for our customers.

The complexity of onco-hematology clinical trials dramatically increased over the last years, due to the increased importance of genetics in this field. But technical and conceptual skills must be aligned to ensure reproducibility, acceptable turnaround times and a high success rate in the competitive market of the pharmaceutical companies. As a consequence, those trials require specialized central laboratories.

Discover how BARC can help you make the difference.